Trident Lifeline Ltd (543616)
🎯 Key Takeaways
- Revenue declined 32.5% QoQ to ₹34 in Q1FY27.
- Market Cap
- ₹484
- P/E Ratio
- 22.5
- P/B Ratio
- 4.82
- ROE
- 20.9%
- ROCE
- 19.4%
- Debt/Equity
- 0.73
- Promoter
- 62.6%
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 31 | 26 | 50 | 34 |
| Operating Profit | 6 | 3 | 10 | 7 |
| OPM % | 19.0% | 10.2% | 19.5% | 20.4% |
| Net Profit | 5 | 5 | 7 | 5 |
| EPS | ₹4.27 | ₹3.72 | ₹5.76 | ₹4.27 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2023 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 12 | 11 | 12 | 12 |
| Reserves | 34 | 53 | 88 | 69 |
| Borrowings | 8 | 54 | 73 | 59 |
| Total Liabilities | 63 | 156 | 237 | 187 |
| Fixed Assets | 1 | 44 | 43 | 36 |
| Investments | 3 | 11 | 8 | 9 |
| Total Assets | 63 | 156 | 237 | 187 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | -10 |
| Investing | -14 |
| Financing | +20 |
| Net Cash Flow | -4 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 63.1% | 64.1% | 62.9% | 62.6% |
| FII | 7.7% | 7.0% | 7.2% | 5.3% |
| DII | 0.4% | 0.3% | 0.3% | 0.3% |
| Public | 17.6% | 17.3% | 18.7% | 20.6% |
| # Shareholders | 554 | 575 | 607 | 709 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.37 L Cr | 36.1 | 18.7% | — | 0.05 |
| DIVISLAB | 2.52 L Cr | 86.0 | 23.0% | — | 0.00 |
| TORNTPHARM | 1.83 L Cr | 76.6 | 15.1% | — | 1.76 |
| ZYDUSLIFE | 1.19 L Cr | 26.6 | 16.8% | — | 0.43 |
| CIPLA | 1.09 L Cr | 32.3 | 13.2% | — | 0.01 |
| LAURUSLABS | 1.07 L Cr | 98.0 | 20.8% | — | 0.45 |
| MANKIND | 1.05 L Cr | 51.4 | 13.9% | — | 0.38 |
| DRREDDY | 1.03 L Cr | 31.9 | 10.1% | — | 0.17 |
| AUROPHARMA | 95,887 | 26.0 | 12.8% | — | 0.20 |
| LUPIN | 93,367 | 16.5 | 27.9% | — | 0.26 |
🔗 Peer Stock Analyses
📋 Recent Filings
- Announcement2026-09-30Trident Lifeline Ltd announced the closure of its trading window effective September 29, 2026, until 48 hours after the board meeting to approve un-au…
- 🔴 Corporate Action2026-09-30Trident Lifeline announced on September 30, 2026, that it acquired an additional 1.00% equity stake in its subsidiary Trident Mediquip Limited, increa…
- 🟡 Board Meeting2026-09-29Trident Lifeline Ltd announced a board meeting on October 5, 2026 to evaluate raising funds via warrants or equity and to set an extraordinary general…
- 🟡 voting results2026-09-28At the 13th AGM on September 26, 2026, shareholders approved all five resolutions including the audited standalone and consolidated financial statemen…
- 🔴 Announcement2026-09-28Trident Lifeline Ltd announced a scheduled one-on-one plant visit with Stylus Holdings on September 28, 2026, in Surat, Gujarat, for investors and ana…
- 🟡 Board Meeting2026-09-26Trident Lifeline held its 13th AGM on September 26, 2026 via video conference, adopting audited standalone and consolidated financial statements for F…
- 🔴 Announcement2026-09-26Trident Lifeline Ltd announced a scheduled plant visit for investors and analysts on October 1, 2026, at its Vapi and Surat facilities in Gujarat, Ind…
- 🔴 Insider Trading2026-09-24Trident Lifeline Ltd clarified that recent share price movement resulted solely from market conditions with no undisclosed material information or ins…
- 🔴 Announcement2026-09-16Trident Lifeline Ltd announced it will participate in a virtual investor conference organized by Arihant Capital on September 25, 2026, at 10.00 AM, a…
- 🔴 Announcement2026-09-08Trident Lifeline Limited received the PHARMEXCIL award for outstanding pharmaceutical exports during 2024-25, presented on September 7, 2026, in New D…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day